Digraph

Antibiotic resistance and pharmaceutical business models

Parent topics

This topic

Recent activity

You must be signed in to add and move topics and links.

2019-02 Aradigm files for bankruptcy
Antibiotic resistance and pharmaceutical business models
2019-04 Achaogen files for bankruptcy
Antibiotic resistance and pharmaceutical business models
2019-07 NHS to pilot a subscription approach to promote the development of new antibiotics
Antibiotic resistance and pharmaceutical business models
2019-08 Centers for Medicaid & Medicare Services announcement about changes to antibiotic reimbursements
Antibiotic resistance and pharmaceutical business models Antimicrobial resistance and government policy Centers for Medicare & Medicaid Services (CMS)
2019-12 Melinta files for bankruptcy
Antibiotic resistance and pharmaceutical business models Melinta Therapeutics Inc
2020-01 World Health Organization releases two reports on the antibiotics pipeline
Antibiotic resistance and pharmaceutical business models World Health Organization and antimicrobial resistance
Antibiotic resistance and subscription-based pharmaceutical business models
Antibiotic resistance and pharmaceutical business models
DISARM Act model legislation
Antibiotic resistance and pharmaceutical business models Antimicrobial resistance and government policy Lobbying and model legislation
A complex solution is possible for antimicrobial resistance, EAM finds | Science|Business
https://sciencebusiness.net/network-updates/complex-solution-possible-antimicrobial-resistance-eam-finds
Antibiotic resistance and pharmaceutical business models
An FDA insider's view of where medical innovation falls short - Los Angeles Times
https://www.latimes.com/science/story/2019-09-07/fda-medical-innovation-falls-short
Antibiotic resistance and pharmaceutical business models
Analysis highlights troubles in the antibiotic pipeline | CIDRAP
https://www.cidrap.umn.edu/news-perspective/2020/04/analysis-highlights-troubles-antibiotic-pipeline
Antibiotic resistance and pharmaceutical business models Cefepime-enmetazobactam
Antibiotic developer Melinta files for bankruptcy | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/12/antibiotic-developer-melinta-files-bankruptcy
2019-04 Achaogen files for bankruptcy 2019-12 Melinta files for bankruptcy Antibiotic resistance and pharmaceutical business models DISARM Act model legislation Delafloxacin Plazomicin
Antibiotic developers are struggling to stay in business, increasing the risk of superbugs
https://www.beckershospitalreview.com/pharmacy/antibiotic-developers-are-struggling-to-stay-in-business-increasing-the-risk-of-superbugs.html
Antibiotic resistance and pharmaceutical business models
Antibiotic resistance: the hidden threat lurking behind Covid-19 - STAT
https://www.statnews.com/2020/03/23/antibiotic-resistance-hidden-threat-lurking-behind-covid-19/
Antibiotic resistance and pharmaceutical business models Covid-19 and antimicrobial resistance DISARM Act model legislation
As Threat of Antibiotic Resistance Mounts, Biotechs Are Running Out of Cash and Time
https://morningconsult.com/2019/09/05/as-threat-of-antibiotic-resistance-mounts-biotechs-are-running-out-of-cash-and-time/
2019-04 Achaogen files for bankruptcy Antibiotic resistance and pharmaceutical business models DISARM Act model legislation Pharmaceutical makers, antibiotic resistance and the development of new drugs Working to Fight AMR
As a virus ravages the world, antibiotic makers are in disarray | PBS NewsHour
https://www.pbs.org/newshour/show/as-a-virus-ravages-the-world-antibiotic-makers-are-in-disarray
Antibiotic resistance and pharmaceutical business models Covid-19 and antimicrobial resistance Eravacycline Ertapenem
Biopharma has abandoned antibiotic development | Hacker News
https://news.ycombinator.com/item?id=21782994
Antibiotic resistance and pharmaceutical business models
Biopharma has abandoned antibiotic development. Here’s why we did, too. – Endpoints News
https://endpts.com/biopharma-has-abandoned-antibiotic-development-heres-why-we-did-too/
Antibiotic resistance and pharmaceutical business models
CMS's 'expanded pathway' will help fight antimicrobial resistance - STAT
https://www.statnews.com/2019/11/06/antimicrobial-resistance-cms-expanded-pathway/
Antibiotic resistance and pharmaceutical business models
Can we make the antibiotic market great again? – Endpoints News
https://endpts.com/can-we-make-the-antibiotic-market-great-again/
Antibiotic resistance and pharmaceutical business models
Commentary: How COVID-19 has added to the problem of drug-resistant antibiotics - Chicago Tribune
https://www.chicagotribune.com/opinion/commentary/ct-opinion-antibiotic-resistant-infections-bacteria-20200727-v6su7usv5bgezkwvjvlqcg6vta-story.html
2019-02 Aradigm files for bankruptcy 2019-04 Achaogen files for bankruptcy AMR Action Fund Antibiotic resistance and pharmaceutical business models Covid-19 and antimicrobial resistance
Congressional watchdog advises HHS to implement ‘post-marketing’ incentives to address dwindling antibiotic development efforts – Endpoints News
https://endpts.com/congressional-watchdog-advises-hhs-to-implement-post-marketing-incentives-to-address-dwindling-antibiotic-development-efforts/
Antibiotic resistance and pharmaceutical business models Covid-19 and antimicrobial resistance
Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - The New York Times
https://www.nytimes.com/2020/06/04/health/coronavirus-antibiotics-drugs.html
1918 Spanish flu pandemic 2002 SARS outbreak Antibiotic resistance and pharmaceutical business models Antibiotic-resistant Clostridioides difficile (C diff)Articles in the New York Times Covid-19 and antimicrobial resistance Working to Fight AMR
Increased CMS Reimbursements for New Antibiotics Represents Progress in Attention to AMR
https://www.newswise.com/articles/increased-cms-reimbursements-for-new-antibiotics-represents-progress-in-attention-to-amr
Antibiotic resistance and pharmaceutical business models
India should lead in the fight against multidrug-resistant pathogens - The Hindu
https://www.thehindu.com/sci-tech/science/india-should-lead-in-the-fight-against-multidrug-resistant-pathogens/article30544299.ece
Antibiotic resistance and pharmaceutical business models Antibiotic resistance genes (ARGs)
Moving from push to pull | Laboratory News
https://www.labnews.co.uk/article/2030234/moving-from-push-to-pull
2019-07 AMR Centre to license Shionogi COT-143 antibody 2019-10 Public Health England report on antibiotic resistance in England Antibiotic resistance and pharmaceutical business models
Panel: Onus to Stop Abx Overuse Is on Prescribers | Medpage Today
https://www.medpagetoday.com/infectiousdisease/publichealth/82703
Antibiotic resistance and pharmaceutical business models Antimicrobial stewardship DISARM Act model legislation Pharmaceutical makers, antibiotic resistance and the development of new drugs
Papers highlight challenges, solutions in developing antibiotics | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/papers-highlight-challenges-solutions-developing-antibiotics
2019-04 Achaogen files for bankruptcy Antibiotic resistance and pharmaceutical business models Carbapenem-resistant Enterobacteriaceae (CRE)Ceftazidime-avibactam Meropenem-vaborbactam Plazomicin
Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a Seat
https://www.contagionlive.com/news/pharmaceutical-companies-and-antimicrobial-stewardship-save-us-a-seat
Antibiotic resistance and pharmaceutical business models Antimicrobial stewardship
Reliance on few drugmakers fuels superbug concerns | News | messenger-inquirer.com
https://www.messenger-inquirer.com/news/reliance-on-few-drugmakers-fuels-superbug-concerns/article_c89aaa86-3ba6-5277-bd47-d03b68083aec.html
Antibiotic resistance and pharmaceutical business models
Responsibly manufactured antimicrobials are a universal necessity - STAT
https://www.statnews.com/2020/01/30/responsibly-manufactured-antimicrobials-universal-necessity/
2019-05 University of York study on antibiotics in rivers AMR Industry Alliance Antibiotic resistance and pharmaceutical business models
Saving lives should be good business. Why doesn’t that apply to finding new antibiotics? - STAT
https://www.statnews.com/2020/03/18/saving-lives-should-be-good-business-why-doesnt-that-apply-to-finding-new-antibiotics/
Antibiotic resistance and pharmaceutical business models DISARM Act model legislation
Socialize Big Pharma Today. Save Your Life Tomorrow.
https://www.jacobinmag.com/2020/04/socialize-big-pharma-antibiotics-artificial-intelligence
2020-02 MIT study reporting a new antibiotic discovered using machine learning Antibiotic resistance and pharmaceutical business models Social democracy
Stewardship / Resistance Scan for Nov 20, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/11/stewardship-resistance-scan-nov-20-2019
Antibiotic resistance and pharmaceutical business models Rapid testing, diagnostics and identification of cause of infection
Stewardship / Resistance Scan for Oct 21, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-21-2019
2019-10 University of Bordeaux study on antibiotic-resistant Helicobacter pylori Antibiotic resistance and pharmaceutical business models
Stewardship vs. Financial Incentives: A False Choice | American Council on Science and Health
https://www.acsh.org/news/2020/02/20/stewardship-vs-financial-incentives-false-choice-14585
Antibiotic resistance and pharmaceutical business models
Superbugs should be entered as a cause of death on death certificates, say experts
https://www.telegraph.co.uk/global-health/science-and-disease/superbugs-should-entered-cause-death-death-certificates-say/
Antibiotic resistance and pharmaceutical business models Antimicrobial resistance in the United Kingdom Jim O'Neill Sally Davies
Sustainable Discovery and Development of Antibiotics — Is a Nonprofit Approach the Future?
https://www.nejm.org/doi/full/10.1056/NEJMp1905589
Antibiotic resistance and pharmaceutical business models
Tackling antimicrobial resistance on multiple fronts - PMLiVE
https://www.pmlive.com/pharma_intelligence/Tackling_antimicrobial_resistance_on_multiple_fronts_1322632
Antibiotic resistance and pharmaceutical business models
Targeting Antibiotic Development | Annals of Internal Medicine | American College of Physicians
https://annals.org/aim/article-abstract/2752699/ensuring-sustainability-needed-antibiotics-aiming-dart-board
Antibiotic resistance and pharmaceutical business models
The Invaluable Role of Antibiotics—in a Pandemic and Beyond | The Pew Charitable Trusts
https://www.pewtrusts.org/en/research-and-analysis/articles/2020/04/15/the-invaluable-role-of-antibiotics-in-a-pandemic-and-beyond
Antibiotic resistance and pharmaceutical business models Covid-19 and antimicrobial resistance
The global antibiotic crisis: a 2020 perspective - PMLiVE
https://www.pmlive.com/pharma_intelligence/The_global_antibiotic_crisis_a_2020_perspective_1328702
AMR Centre Antibiotic resistance and pharmaceutical business models DISARM Act model legislation
There's a way for modern medicine to cure diseases even when the treatments aren't profitable - Baltimore Sun
https://www.baltimoresun.com/sns-theres-a-way-for-modern-medicine-to-cure-diseases-even-when-the-treatments-arent-profitable-122294-20190916-story.html
Antibiotic resistance and pharmaceutical business models
Tracking the Global Pipeline of Antibiotics in Development | The Pew Charitable Trusts
https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2019/09/tracking-the-global-pipeline-of-antibiotics-in-development
2016 21st Century Cures Act Antibiotic resistance and pharmaceutical business models Carbapenem-resistant Acinetobacter baumannii (CRAB, CR-Ab)
Tracking the Global Pipeline of Antibiotics in Development, April 2020 | The Pew Charitable Trusts
https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2020/04/tracking-the-global-pipeline-of-antibiotics-in-development
Antibiotic resistance and pharmaceutical business models
UK report cites lack of progress on AMR Review steps | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/uk-report-cites-lack-progress-amr-review-steps
AMR Review Antibiotic resistance and pharmaceutical business models Jim O'Neill
Why Antibiotic Resistance Is Ignored by Big Pharma
https://www.menshealth.com/health/a30715597/antibiotic-resistance-drug-companies/
Antibiotic resistance and pharmaceutical business models
Why developing new antibiotics is a matter of life and death – The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com
https://europeansting.com/2020/01/29/why-developing-new-antibiotics-is-a-matter-of-life-and-death/
Antibiotic resistance and pharmaceutical business models
World AMR Congress: Fighting Anti-Microbial Resistance | BioSpace
https://www.biospace.com/article/world-amr-congress-fighting-anti-microbial-resistance/
2019-04 Achaogen files for bankruptcy Antibiotic resistance and pharmaceutical business models Plazomicin Working to Fight AMR
‘No antibiotic works for patients with multidrug-resistant infections’ - Korea Biomedical Review
http://www.koreabiomed.com/news/articleView.html?idxno=6403
Antibiotic resistance and pharmaceutical business models Antimicrobial resistance in South Korea